Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels.

doi:10.1016/j.neulet.2019.134653

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels.

Neuroscience letters - 18 Jan 2020

Sanna Angela, Follesa Paolo, Puligheddu Monica, Cannas Antonino, Serra Mariangela, Pisu Maria Giuseppina, Dagostino Sabino, Solla Paolo, Tacconi Paolo, Marrosu Francesco

Abstract excerpt

Patients with Parkinson's Disease (PD) experience bothersome motor fluctuations and Levodopa-induced Dyskinesias (LIDs). Cerebellar continuous theta burst stimulation (cTBS) was used as an inhibitory protocol of repetitive transcranial magnetic stimulation (rTMS) to reduce LIDs in PD patients. The influence of Val66Met polymorphism of Brain Derived Neurotrophic Factor (BDNF) gene on the therapeutic response to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cerebellum
Share to Aged
Share to Antiparkinson Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Brain-Derived Neurotrophic Factor

Share to Dyskinesia, Drug-Induced

Share to Levodopa

Share to Parkinson Disease

Share to Transcranial Magnetic Stimulation

Source

Open in PubMed

Identifiers

PMID: 31778767
DOI: 10.1016/j.neulet.2019.134653

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.